Could cause temporary or reversible harm; serious harm is unlikely.
Defective container; inadequately sealed blister packaging.
| Brand name | MIDODRINE HYDROCHLORIDE |
| Generic name | MIDODRINE HYDROCHLORIDE |
| Active ingredient(s) | MIDODRINE HYDROCHLORIDE |
| Distributed by / for | Major Pharmaceuticals, Indianapolis, IN 46268 USA |
| NDC | 0904-6818-06 |
| Full product label | Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. |
| Recalling firm | The Harvard Drug Group LLC |
| Distribution | Nationwide US. |
| Quantity | 8892 cartons |
| Recall initiated | 2026-02-17 |
| Report date | 2026-03-11 |
| Recall completed | — |
| Recall number | D-0383-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗